Japan's Pharma & Biotech Companies Push API Development

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Chugai Pharma Manufacturing Company Limited (Tokyo, Japan), one of the largest pharmaceutical companies in Japan, expects to begin construction next year on its Ukima Plant in Tokyo, nicknamed "UKX."

Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can learn more from a detailed project report and plant profile.

UKX is one of many initiatives across Japan that is designed to accelerate the research and development of manufacturing processes for active pharmaceutical ingredients (APIs), which are becoming increasingly complex.

Industrial Info is tracking about US$500 million worth of commercial, physical and biological research projects across Japan's Pharmaceutical & Biotech Industry. Subscribers can click here for a full list of detailed project reports.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) platform helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 trillion (USD).